Company profile
Sarepta Therapeutics, Inc. Insider Trading
SRPTEvery SEC Form 4 insider trading filing for Sarepta Therapeutics, Inc. (SRPT) since April 2023: open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- Nasdaq
- Sector
- Pharmaceutical Preparations
- CIK
- 0000873303
- Filings
- 130
- Insiders
- 17
- Last filing
- 2026-09-04
Activity summary
No discretionary insider buying or selling in the last 30 days. The 4 transactions filed were grants, option exercises or other non-open-market activity.
Three year balance
Buy and sell value by quarter, Q4 23 to Q3 26. Sarepta Therapeutics, Inc. insiders are net sellers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $10.7M.
90 day insight
Over the last 90 days, Sarepta Therapeutics, Inc. insiders filed 6 Form 4 transactions, none of which were open-market purchases or sales.
- Most active insider: Michael Severino with 2 transactions totaling $0.
Activity skews bullish: buys outpace sales.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
Showing 5 of 50 transactions. The most significant are picked first.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 4, 2026 | Louise Rodino-Klapac | SRPT | Tax Withholding | 21,423 | $22.22 | $476K |
| Sep 4, 2026 | Cristin Rothfuss | SRPT | Tax Withholding | 22,025 | $22.22 | $489K |
| Sep 4, 2026 | Ian Michael Estepan | SRPT | Tax Withholding | 24,799 | $22.22 | $551K |
| Sep 4, 2026 | Ryan Ho-Yan Wong | SRPT | Tax Withholding | 13,272 | $22.22 | $295K |
| Mar 12, 2026 | Stephen Mayo | SRPT | Sale | 7,239 | $17.02 | $123K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=SRPT" \
-H "X-Api-Key: $KEY"Get a keyInstitutional Ownership
Top 13F-HR holders of Sarepta Therapeutics, Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings: institutional holders report positions within 45 days of quarter end. Joined with insider activity above: see who's loading up institutionally while insiders are trading. Full 13F-HR API →